|
DAVH protocol
|
C061002 |
|
|
VMBP protocol
|
C036046 |
|
|
TAVH protocol
|
C061003 |
|
|
3 beta-hydroxy-13 alpha-amino-13,17-seco-5 alpha-androstan-17-oic-13,17-lactam
|
C036047 |
|
|
benidipine
|
C061004 |
|
|
BW 785U
|
C036048 |
|
|
1-methyl-2-((4-aminophenyl)sulfonyl)amino-5-nitroimidazole
|
C061005 |
|
|
isodent
|
C061006 |
|
|
5-(N-ethyl-(2'-methoxy-5'-nitrobenzyl))amiloride
|
C061007 |
|
|
GGTI-2154
|
C482418 |
|
|
2,6-anhydro-4,5,7-tri-O-benzyl-3-(N-benzylacetamido)-3-deoxy-glycero-ido-heptitol
|
C457460 |
|
|
asparoffin C
|
C000616020 |
|
|
Ultracid F
|
C482400 |
|
|
asparoffin D
|
C000616021 |
|
|
Kinzalkomb
|
C482401 |
|
|
5-acetoxy-6,7,8,3',4'-pentamethoxyflavone
|
C000616022 |
|
|
20-O-(beta-D-glucopyranosyl)-20(S)-protopanaxadiol
|
C482402 |
|
|
AS01B adjuvant
|
C000616023 |
|
|
mGSTA4-4
|
C482403 |
|
|
cis-1-methyl-7-((4-(2,6-dichlorophenyl)piperidin-1-yl)methyl)-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol
|
C482404 |
|
